OrbiMed’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

OrbiMed’s Portfolio DSCI Stock Details DSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-300,000	Closed	-$2.54M	–	164
2015 Q1	$2.54M	Hold	300,000	–	–	0.02%	123
2014 Q4	$2.79M	Hold	300,000	–	–	0.03%	119
2014 Q3	$2.5M	Hold	300,000	–	–	0.03%	121
2014 Q2	$3.47M	Hold	300,000	–	–	0.04%	119
2014 Q1	$3.8M	Buy	+300,000	New	+$3.88M	0.05%	123

Other funds holding DSCI

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed's DSCI Position: Q2 2015 in Review

OrbiMed sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q2 2015, closing a stake of 300,000 shares — an estimated $2.54M sold.

OrbiMed first reported a position in DSCI in Q1 2014 and held it in 5 quarters. The position peaked at $3.8M in Q1 2014. 62 funds tracked by Wall St. Rank hold DSCI as of Q2 2015.

OrbiMed reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q2 2015 after selling out during the quarter.
OrbiMed sold 300,000 Derma Sciences, Inc. Common Stock (DE) shares in Q2 2015, an estimated $2.54M.
OrbiMed first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q1 2014 and held it in 5 quarters.
OrbiMed's Derma Sciences, Inc. Common Stock (DE) position peaked at $3.8M in Q1 2014.
62 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q2 2015.

Based on OrbiMed's 13F filing for Q2 2015, filed 14 Aug 2015.